10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2020 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 10, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Cash Flows From Operating Activities: | |||
| Net (Loss)/Earnings | $ (8,995) | 3,460 | 4,947 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization, net | 10,380 | 1,746 | 637 |
| Deferred income taxes | 983 | (924) | 45 |
| Stock-based compensation | 779 | 441 | 221 |
| Impairment charges | 1,203 | 199 | 126 |
| Pension settlements and amortization | 43 | 1,688 | 186 |
| Divestiture gains and royalties | (699) | (1,855) | (992) |
| MyoKardia Asset Acquisition IPRD Charge | 11,438 | 0 | 0 |
| Asset acquisition charges | 1,099 | 63 | 1,211 |
| Gain (Loss) on Investments, Excluding Other than Temporary Impairments | 1,228 | 275 | (513) |
| Equity investment (gains)/losses | (1,228) | (275) | 513 |
| Contingent consideration fair value adjustments | (1,757) | 523 | 0 |
| Other adjustments | (177) | (26) | (45) |
| Changes in operating assets and liabilities: | |||
| Receivables | (646) | 752 | (429) |
| Inventories | 2,672 | 463 | (216) |
| Accounts payable | 188 | 229 | (59) |
| Income taxes payable | (2,305) | 907 | 203 |
| Other | 1,074 | 819 | 718 |
| Net Cash Provided by Operating Activities | 14,052 | 8,210 | 7,066 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable securities | 6,280 | 3,809 | 2,379 |
| Purchase of marketable securities | (4,172) | (3,961) | (2,305) |
| Capital expenditures | (753) | (836) | (951) |
| Divestiture and other proceeds | 870 | 15,852 | 1,249 |
| Acquisition and other payments, net of cash acquired | (13,084) | (24,777) | (2,372) |
| Net Cash Used in Investing Activities | (10,859) | (9,913) | (2,000) |
| Cash Flows From Financing Activities: | |||
| Short-term borrowings, net | (267) | 131 | (543) |
| Issuance of long-term debt | 6,945 | 26,778 | 0 |
| Repayment of long-term debt | (2,750) | (9,256) | (5) |
| Repurchase of common stock | (1,546) | (7,300) | (320) |
| Dividends | (4,075) | (2,679) | (2,613) |
| Other | 542 | (53) | (54) |
| Net Cash (Used in)/Provided by Financing Activities | (1,151) | 7,621 | (3,535) |
| Effect of Exchange Rate on Cash, Cash Equivalents and Restricted Cash | 111 | (9) | (41) |
| Increase in Cash, Cash Equivalents and Restricted Cash | 2,153 | 5,909 | 1,490 |
| Cash, Cash Equivalents and Restricted Cash | 14,973 | 12,820 | 6,911 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |